Manso, L., Sanchez-Muñoz, A., Calvo, I., et al. Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer. Breast Care 2018;13:277–283. DOI: 10.1159/000488794

Acceso a PubMed

Acceso al archivo PDF